Hemogenyx Pharmaceuticals Plc
HOPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $311 | $159 | $1,643 | $1,248 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $471 | $4 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $4 | $828 | $4 |
| Total Curr. Assets | $782 | $839 | $2,471 | $2,170 |
| Property Plant & Equip (Net) | $3,010 | $2,727 | $3,007 | $3,312 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $250 | $477 | $473 | $441 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $215 | $168 | $166 | $182 |
| Total NC Assets | $3,475 | $3,373 | $3,646 | $3,936 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,257 | $4,212 | $6,116 | $6,106 |
| Liabilities | – | – | – | – |
| Payables | $0 | $683 | $309 | $302 |
| Short-Term Debt | $568 | $530 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | -$302 |
| Other Curr. Liab. | $1,248 | -$478 | $0 | $0 |
| Total Curr. Liab. | $1,816 | $1,159 | $564 | $652 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $735 | $0 | $0 | $0 |
| Total NC Liab. | $3,192 | $2,199 | $2,529 | $2,673 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $2,623 | $2,784 | $2,673 |
| Total Liabilities | $5,008 | $3,358 | $3,093 | $3,325 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $19,259 | $35 | $13,418 | $11,756 |
| Retained Earnings | -$55,716 | -$29,424 | -$26,618 | -$23,805 |
| AOCI | $4,296 | $8,898 | -$5,173 | -$5,071 |
| Other Equity | $0 | $0 | -$0 | $0 |
| Total Equity | -$687 | $898 | $3,064 | $2,819 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$64 | -$44 | -$40 | -$38 |
| Total Liab. & Tot. Equity | $4,257 | $4,212 | $6,116 | $6,106 |
| Net Debt | $256 | $371 | -$1,643 | -$1,248 |